Altered gene expression profiling in endometrium: Evidence for progesterone resistance

Seminars in Reproductive Medicine

Volumn 28, Issue 1, 2010, Pages 51-58

  Aghajanova, Lusine ^a   Velarde, Michael C ^a   Giudice, Linda C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CAMP; Endometriosis; Progesterone resistance

Indexed keywords

8 BROMO CYCLIC AMP; COMPLEMENTARY DNA; CYCLIC AMP; CYPROTERONE ACETATE; ESTRADIOL; ETHINYLESTRADIOL; G PROTEIN COUPLED RECEPTOR; GENOMIC DNA; INTERLEUKIN 1BETA; MEDROXYPROGESTERONE; PLACEBO; PROGESTERONE; PROGESTERONE RECEPTOR;

DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE INFERTILITY; GENE EXPRESSION; GYNECOLOGIC DISEASE; HORMONAL THERAPY; HORMONE RESISTANCE; HUMAN; INFERTILITY THERAPY; MENSTRUAL CYCLE; MICROARRAY ANALYSIS; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PREGNANCY RATE; PROGESTERONE RESISTANCE; REVIEW; TREATMENT OUTCOME;

ANIMALS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; RECEPTORS, PROGESTERONE; UTERINE NEOPLASMS;

EID: 76249109688     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0029-1242994     Document Type: Review

References (76)

1. Tabibzadeh S. Molecular control of the implantation window. Hum Reprod Update 1998 4 (5) 465-471
2. Giudice L C. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 2006 20 (2) 235-244
3. Talbi S, Hamilton A E., Vo K C. et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006 147 (3) 1097-1121
4. Giudice L C. Potential biochemical markers of uterine receptivity. Hum Reprod 1999 14 (Suppl 2) 3-16
5. Lessey B A. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids 2003 68 (10-13) 809-815
6. Gellersen B, Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol 2003 178 (3) 357-372
7. Aghajanova L, Hamilton A, Kwintkiewicz J, Vo K C., Giudice L C. Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis. Biol Reprod 2009 80 (1) 105-114
8. Gellersen B, Brosens I A., Brosens J J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med 2007 25 (6) 445-453
9. Giudice L C., Kao L C. Endometriosis. Lancet 2004 364 (9447) 1789-1799
10. Sampson J A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 1927 14 422-469
11. Eskenazi B, Warner M L. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997 24 (2) 235-258
12. Ryan I P., Taylor R N. Endometriosis and infertility: new concepts. Obstet Gynecol Surv 1997 52 (6) 365-371
13. Giudice L C., Telles T L., Lobo S, Kao L. The molecular basis for implantation failure in endometriosis: on the road to discovery. Ann N Y Acad Sci 2002 955 252-264 discussion 293-255 396-406
14. Kim J J., Taylor H S., Lu Z et al. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod 2007 13 (5) 323-332
15. Noble L S., Simpson E R., Johns A, Bulun S E. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996 81 (1) 174-179
16. Matsuzaki S, Canis M, Vaurs-Barrière C et al. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod 2004 10 (10) 719-728
17. Kao L C., Germeyer A, Tulac S et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003 144 (7) 2870-2881
18. Matsuzaki S, Canis M, Vaurs-Barrière C, Boespflug-Tanguy O, Dastugue B, Mage G. DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection. Fertil Steril 2005 84 (Suppl 2) 1180-1190
19. Wu Y, Kajdacsy-Balla A, Strawn E et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 2006 147 (1) 232-246 (Pubitemid 43004277)
20. Mettler L, Salmassi A, Schollmeyer T, Schmutzler A G., Püngel F, Jonat W. Comparison of c-DNA microarray analysis of gene expression between eutopic endometrium and ectopic endometrium (endometriosis). J Assist Reprod Genet 2007 24 (6) 249-258
21. Eyster K M., Klinkova O, Kennedy V, Hansen K A. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 2007 88 (6) 1505-1533
22. Burney R O., Talbi S, Hamilton A E. et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007 148 (8) 3814-3826
23. Sherwin J R., Sharkey A M., Mihalyi A, Simsa P, Catalano R D., D'Hooghe T M. Global gene analysis of late secretory phase, eutopic endometrium does not provide the basis for a minimally invasive test of endometriosis. Hum Reprod 2008 23 (5) 1063-1068
24. Lebovic D I., Baldocchi R A., Mueller M D., Taylor R N. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril 2002 78 (4) 849-854
25. Slayden O D., Keator C S. Role of progesterone in nonhuman primate implantation. Semin Reprod Med 2007 25 (6) 418-430
26. Conneely O M., Maxwell B L., Toft D O., Schrader W T., O'Malley B W. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun 1987 149 (2) 493-501
27. Kastner P, Krust A, Turcotte B et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990 9 (5) 1603-1614
28. Tora L, Gronemeyer H, Turcotte B, Gaub M P., Chambon P. The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 1988 333 (6169) 185-188
29. Vegeto E, Shahbaz M M., Wen D X., Goldman M E., O'Malley B W., McDonnell D P. Human progesterone receptor A form is a cell-and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 1993 7 (10) 1244-1255
30. Mulac-Jericevic B, Mullinax R A., DeMayo F J., Lydon J P., Conneely O M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000 289 (5485) 1751-1754
31. Conneely O M., Mulac-Jericevic B, DeMayo F, Lydon J P., O'Malley B W. Reproductive functions of progesterone receptors. Recent Prog Horm Res 2002 57 339-355
32. Nisolle M, Casanas-Roux F, Wyns C, de Menten Y, Mathieu P E., Donnez J. Immunohistochemical analysis of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: a new quantitative method. Fertil Steril 1994 62 (4) 751-759
33. Prentice A, Randall B J., Weddell A et al. Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium. Hum Reprod 1992 7 (9) 1318-1325
34. Attia G R., Zeitoun K, Edwards D, Johns A, Carr B R., Bulun S E. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000 85 (8) 2897-2902
35. Bergqvist A, Fernö M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum Reprod 1993 8 (12) 2211-2217 (Pubitemid 24012826)
36. Bergqvist A, Fernö M. Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence. Fertil Steril 1993 60 (1) 63-68 (Pubitemid 23198920)
37. Jänne O, Kauppila A, Kokko E, Lantto T, Rönnberg L, Vihko R. Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue. Am J Obstet Gynecol 1981 141 (5) 562-566
38. Lyndrup J, Thorpe S, Glenthøj A, Obel E, Sele V. Altered progesterone/estrogen receptor ratios in endometriosis. A comparative study of steroid receptors and morphology in endometriosis and endometrium. Acta Obstet Gynecol Scand 1987 66 (7) 625-629
39. Lessey B A., Metzger D A., Haney A F., McCarty K S. Jr. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 1989 51 (3) 409-415
40. Wu Y, Strawn E, Basir Z, Halverson G, Guo S W. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 2006 1 (2) 106-111
41. Aghajanova L, Velarde M C., Giudice L C. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis. Endocrinology 2009 150 (8) 3863-3870
42. Gentilini D, Vigano P, Carmignani L, Spinelli M, Busacca M, Di Blasio A M. Progesterone receptor+331G/A polymorphism in endometriosis and deep-infiltrating endometriosis. Fertil Steril 2008 90 (4) 1243-1245
43. van Kaam K J., Romano A, Schouten J P., Dunselman G A., Groothuis P G. Progesterone receptor polymorphism+331G/A is associated with a decreased risk of deep infiltrating endometriosis. Hum Reprod 2007 22 (1) 129-135
44. Klemmt P A., Carver J G., Kennedy S H., Koninckx P R., Mardon H J. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril 2006 85 (3) 564-572
45. Brar A K., Handwerger S, Kessler C A., Aronow B J. Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol Genomics 2001 7 (2) 135-148
46. Buzzio O L., Lu Z, Miller C D., Unterman T G., Kim J J. FOXO1A differentially regulates genes of decidualization. Endocrinology 2006 147 (8) 3870-3876
47. Lee B, Du H, Taylor H S. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod 2009 80 (1) 79-85
48. Fazleabas A T., Brudney A, Chai D, Langoi D, Bulun S E. Steroid receptor and aromatase expression in baboon endometriotic lesions. Fertil Steril 2003 80 (Suppl 2) 820-827
49. Jackson K S., Brudney A, Hastings J M., Mavrogianis P A., Kim J J., Fazleabas A T. The altered distribution of the steroid hormone receptors and the chaperone immunophilin FKBP52 in a baboon model of endometriosis is associated with progesterone resistance during the window of uterine receptivity. Reprod Sci 2007 14 (2) 137-150 (Pubitemid 351168833)
50. Hirota Y, Tranguch S, Daikoku T et al. Deficiency of immunophilin FKBP52 promotes endometriosis. Am J Pathol 2008 173 (6) 1747-1757
51. Telimaa S, Puolakka J, Rönnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987 1 (1) 13-23
52. Telimaa S, Rönnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. Gynecol Endocrinol 1987 1 (4) 363-371
53. Fedele L, Arcaini L, Bianchi S, Baglioni A, Vercellini P. Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis. Obstet Gynecol 1989 73 (6) 1000-1004
54. Pal L, Shifren J L., Isaacson K B., Chang Y, Leykin L, Toth T L. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer. J Assist Reprod Genet 1998 15 (1) 27-31 (Pubitemid 28093024)
55. Tummon I S., Colwell K A., Mackinnon C J., Nisker J A., Yuzpe A A. Abbreviated endometriosis-associated infertility correlates with in vitro fertilization success. J In Vitro Fert Embryo Transf 1991 8 (3) 149-153
56. Geber S, Paraschos T, Atkinson G, Margara R, Winston R M. Results of IVF in patients with endometriosis: the severity of the disease does not affect outcome, or the incidence of miscarriage. Hum Reprod 1995 10 (6) 1507-1511
57. Pellicer A, Oliveira N, Ruiz A, Remohí J, Simón C. Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryo development and implantation in assisted reproduction. Hum Reprod 1995 10 (Suppl 2) 91-97
58. Apridonidze T, Essah P A., Iuorno M J., Nestler J E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005 90 (4) 1929-1935
59. Essah P A., Nestler J E. Metabolic syndrome in women with polycystic ovary syndrome. Fertil Steril 2006 86 (Suppl 1) S18-S19
60. Qiao J, Wang L, Li R, Zhang X. Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome. Reprod Biomed Online 2008 17 (3) 425-435
61. Savaris R, Groll J M., Young S L. et al. Insulin and progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. Paper presented at: 24th Annual Meeting of the European Society of Human Reproduction and Embryology 2008 Barcelona, Spain
62. Gambrell R D. Jr, Bagnell C A., Greenblatt R B. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review. Am J Obstet Gynecol 1983 146 (6) 696-707
63. Montgomery B E., Daum G S., Dunton C J. Endometrial hyperplasia: a review. Obstet Gynecol Surv 2004 59 (5) 368-378
64. Mencaglia L, Valle R F., Perino A, Gilardi G. Endometrial carcinoma and its precursors: early detection and treatment. Int J Gynaecol Obstet 1990 31 (2) 107-116
65. Linkov F, Edwards R, Balk J et al. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. Eur J Cancer 2008 44 (12) 1632-1644
66. Pérez-Medina T, Bajo J, Folgueira G, Haya J, Ortega P. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up. Gynecol Oncol 1999 73 (2) 299-304
67. Podczaski E, Kaminski P, Gurski K et al. Detection and patterns of treatment failure in 300 consecutive cases of early endometrial cancer after primary surgery. Gynecol Oncol 1992 47 (3) 323-327
68. Normanno N, Di Maio M, De Maio E et al, NCI-Naple Breast Cancer Group. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. Endocr Relat Cancer 2005 12 (4) 721-747
69. Zupi E, Sbracia M, Marconi D et al. TNFalpha expression in hyperplastic endometrium. Am J Reprod Immunol 2000 44 (3) 153-159
70. Zhao S, Chen X, Lu X, Yu Y, Feng Y. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma. Gynecol Oncol 2007 105 (1) 45-54
71. Shen Z Q., Zhu H T., Lin J F. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives. Obstet Gynecol 2008 112 (2 Pt 2) 465-467
72. Amezcua C A., Zheng W, Muderspach L I., Felix J C. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia. Gynecol Oncol 1999 73 (1) 126-136
73. Wang S, Pudney J, Song J, Mor G, Schwartz P E., Zheng W. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasiaprecursor of endometrial cancer. Gynecol Oncol 2003 88 (2) 108-117
74. Amezcua C A., Lu J J., Felix J C., Stanczyk F Z., Zheng W. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Gynecol Oncol 2000 79 (2) 169-176
75. Chen X, Zhang Z, Feng Y et al. Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance. Mod Pathol 2009 22 (5) 699-708
76. Huang G S., Arend R C., Li M et al. Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma. Am J Obstet Gynecol 2009 200 (4) 451-455